Cerebral vasculitis (sometimes the word angiitis is used instead of "vasculitis") is vasculitis (inflammation of the blood vessel wall) involving the brain and occasionally the spinal cord. It affects all of the vessels: very small blood vessels (capillaries), medium-size blood vessels (arterioles and venules), or large blood vessels (arteries and veins). If blood flow in a vessel with vasculitis is reduced or stopped, the parts of the body that receive blood from that vessel begins to die. It may produce a wide range of neurological symptoms, such as headache, skin rashes, feeling very tired, joint pains, difficulty moving or coordinating part of the body, changes in sensation, and alterations in perception, thought or behavior, as well as the phenomena of a mass lesion in the brain leading to coma and herniation. Some of its signs and symptoms may resemble multiple sclerosis. 10% have associated bleeding in the brain.
Contents
1 Causes
2 Diagnosis
3 Treatment
4 Specific Diseases
4.1 Giant cell arteritis (GCA)
4.1.1 Symptoms
4.1.2 Diagnostic criteria
4.2 Takayasu's arteritis
4.2.1 Symptoms
4.2.2 Classification criteria
4.2.3 Treatment therapy
4.3 Polyarteritis nodosa (PAN)
4.3.1 Symptoms
4.3.2 Diagnostic Criteria
4.3.3 Treatment therapy
4.4 Granulomatosis with polyangiitis (GPA)
4.4.1 Symptoms
4.4.2 Diagnostic Criteria
4.4.3 Treatment Therapy
5 参考
6 External links
Causes
"Primary" angiitis/vasculitis of the central nervous system (PACNS) is said to be present if there is no underlying cause. The exact mechanism of the primary disease is unknown, but the fundamental mechanism of all vasculitides is autoimmunity. Other possible secondary causes of cerebral vasculitis are infections, systemic auto-immune diseases such as systemic lupus erythematosus (SLE) and rheumatoid arthritis, medications and drugs (amphetamine, cocaine and heroin), some forms of cancer (lymphomas, leukemia and lung cancer) and other forms of systemic vasculitis such as granulomatosis with polyangiitis, polyarteritis nodosa or Behçet's disease. It may imitate, and is in turn imitated by, a number of other diseases that affect the blood vessels of the brain diffusely such as fibromuscular dysplasia and thrombotic thrombocytopenic purpura. The disease may get initiated by inhaling roach spray like PIF-PAF containing ingredients such as pyrethroids, permethrin etc.
Diagnosis
Cerebral angiography and magnetic resonance imaging, family medical history, symptoms, a complete physical examination, and ultimately biopsy of the brain, are often required for the diagnosis. Also, many lab tests must be done for the diagnosis; tests may reveal anemia (a shortage of red blood cells), a high white blood cell count, a high platelet count, allergic reactions, immune complexes, antibodies (tools the body uses to fight off threats) and elevation of inflammatory markers. Another crucial part in the diagnosis of cerebral vasculitis is the use of imaging techniques. Techniques such as conventional digital subtraction angiography (DSA) and magnetic resonance imaging (MRI) are used to find and monitor cerebral involvement.
Treatment
Treatment is first with many different high-dose steroids, namely glucocorticoids. Then, if symptoms do not improve additional immunosuppression such as cyclophosphamide are added to decrease the immune system's attack on the body's own tissues. Cerebral vasculitis is a very rare condition that is difficult to diagnose, and as a result there are significant variations in the way it is diagnosed and treated.
Specific Diseases
This article needs editing for compliance with Wikipedia's Manual of Style. In particular, it has problems with not using MEDMOS. Please help improve it if you can. (December 2017) (Learn how and when to remove this template message)
Giant cell arteritis (GCA)
(Also known as temporal arteritis)
Symptoms
Fever
general uneasiness
weight loss
inflammation of the muscles causing stiffness in the shoulders; neck; and/or upper arms
persisting headache
pain in the jaw or ear while eating
double vision
partial loss of vision or blind spots
(on rare occasions) stroke.
Diagnostic criteria
Three or more of the following five criteria must be met:
Age 50 years or more
New developed headache
Tenderness of the superficial temporal artery
Elevated sedimentation rate, at least 50 mm/hour (blood test that reveals inflammatory activity)
Giant cell arteritis in a biopsy specimen from the temporal artery
Takayasu's arteritis
Symptoms
Starts with nonspecific symptoms such as:
Localized joint pain
Fever
Fatigue
Headaches
Rashes
Weight loss
Diagnosis usually does not happen until the blockage causes deficient blood flow to the extremities or to a stroke.
Classification criteria
Three or more of the following six criteria must be met:
Age when disease starts is under 50
Decreased brachial artery pulse
Systolic blood pressure differs by more than 10mmHg between arms
Cramping caused by exercise in the extremities
Abnormal sounds (through stethoscope) over subclavian arteries or abdominal aorta
A narrowing or blockage in the aorta, its primary branches, or large arteries as seen through a radiograph of the arteries.
Treatment therapy
50% of patients respond to corticosteroid therapy alone in early phases
Methotrexate or Azathioprine are an alternative to corticosteroid immunosuppressants
There have been studies on Mycophenolate mofetil and anti-TNF therapies
In Takayasu’s arteritis it is vital to combine drug treatments often with low-dose aspirin or statin
Polyarteritis nodosa (PAN)
Symptoms
Systemic illness with fever
General feeling of discomfort or uneasiness with cause difficult to identify
Weight loss
Arthritis
Black discoloration of skin primarily on the extremities
Severe inadequate blood supply to the extremities
Ischemic stroke, hemorrhages and a progressive encephalopathy with or without seizures may occur
Diagnostic Criteria
Three or more of the following ten criteria are required:
More than 4 kg (8.8 lb) weight loss
Lace-like purplish discoloration of the skin (livedo reticularis)
Testicular pain
Pain in a muscle or group of muscles (myalgias)
Damage to peripheral nerves
Elevation of blood pressure by more than 90 mmHg
Creatinine serum levels greater than 1,5 mg/dl
Hepatitis B or C virus antibodies
An aneurysm or occlusion as shown in a pathologic arteriography
Histology findings typical of PAN
Treatment therapy
In PAN not associated with a hepatitis virus: prednisone and cyclophosphamide therapy. In case of emergency, plasmapheresis may be tried
In PAN associated with a hepatitis virus: combination therapy of prednisone along with a virustatic, such as lamivudine (Hepatitis B) or interferon-alpha and ribavirin (Hepatitis C)
Granulomatosis with polyangiitis (GPA)
Symptoms
Men are affected twice as often as women
Compression of structures surrounding the nose and paranasal sinuses
Diabetes insipidus
Abnormal protrusion of the eyeball(s)
Nonseptic meningitis
Affection of the lung and kidney due to destruction of the arteries and veins
Ischemic stroke, hemorrhages, or encephalopathy with possible seizures
Diagnostic Criteria
Two or more of the following four criteria are required:
Necrotizing ulcerating inflammation of nose, sinuses, mouth or pharynx
Irregular lung infiltrates
Nephritis
Granulomatous vascular and perivascular inflammation
Treatment Therapy
Corticosteroids (e.g., Prednisolone)
Cyclophosphamide
Azathioprine
Mycophenolate mofetil
参考
"Cerebral Vasculitis". Prime Health Channel. 19 December 2012. Retrieved 1 May 2015.
Scolding NJ, Jayne DR, Zajicek JP, Meyer PA, Wraight EP, Lockwood CM (January 1997). "Cerebral vasculitis--recognition, diagnosis and management". QJM. 90 (1): 61–73. doi:10.1093/qjmed/90.1.61. PMID 9093590.
Rehman HU (November 2000). "Primary angiitis of the central nervous system". J R Soc Med. 93 (11): 586–8. doi:10.1177/014107680009301108. PMC 1298150. PMID 11198690. Archived from the original (PDF) on 2009-11-05. Retrieved 2008-07-23.
"Central Nervous System Vasculitis (CNS Vasculitis)". Cleveland Clinic. Retrieved 1 May 2015.
Scolding NJ, Wilson H, Hohlfeld R, Polman C, Leite I, Gilhus N (July 2002). "The recognition, diagnosis and management of cerebral vasculitis: a European survey". Eur. J. Neurol. 9 (4): 343–7. doi:10.1046/j.1468-1331.2002.00422.x. PMID 12099915. Archived from the original on 2013-01-05.
Berlit, Peter (1 October 2010). "Diagnosis and treatment of cerebral vasculitis". Therapeutic Advances in Neurological Disorders. 3 (1): 29–42. doi:10.1177/1756285609347123. ISSN 1756-2864. PMC 3002614. PMID 21180634. |
